Spasmodic Dysphonia Pain

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions

Spasmodic Dysphonia

Interventions

DRUG

Lidocaine

Subcutaneous injection 0.5cc 2% in 1:100,000 epinephrine

DEVICE

Vibrating wand

a vibrating instrument held adjacent to the cricothyroid space

Trial Locations (1)

Mayo Clinic in Arizona, Phoenix